Drug-eluting stents: Are they still the answer?

Michael A. Brown, Trung H.D. Tran, Ronald J. Krone

Research output: Contribution to journalArticle

Abstract

Drug-eluting stents have profoundly impacted the interventional cardiology field. Their efficacy against the smooth muscle hyperplasia responsible for in-stent restenosis has significantly altered practice patterns and patient selection for percutaneous and surgical revascularization. However, their potent antiproliferative properties and polymer coatings delay the healing process of the arterial wall and appear to prolong the duration of stent thrombogenicity. The actual clinical impact of this effect is controversial. However, the sequelae of stent thrombosis can be catastrophic and have driven much recent discussion on this subject. This article attempts to provide perspective on the benefits and limitations of these devices so that their use achieves maximum benefit and lowest risk.

Original languageEnglish
Pages (from-to)334-341
Number of pages8
JournalCurrent Cardiovascular Risk Reports
Volume2
Issue number5
DOIs
StatePublished - Dec 1 2008

Fingerprint Dive into the research topics of 'Drug-eluting stents: Are they still the answer?'. Together they form a unique fingerprint.

  • Cite this